A genome-wide DNA methylation study in colorectal carcinoma

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Kibriya, Muhammad G ^a   Raza, Maruf ^b   Jasmine, Farzana ^a   Roy, Shantanu ^a   Paul Brutus, Rachelle ^a   Rahaman, Ronald ^a   Dodsworth, Charlotte ^a   Rakibuz Zaman, Muhammad ^a   Kamal, Mohammed ^b   Ahsan, Habibul ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BIOLOGICAL MARKER; ESTROGEN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; RAC GUANINE NUCLEOTIDE BINDING PROTEIN; RETINOIC ACID RECEPTOR; UNCLASSIFIED DRUG; DNA;

ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; ENZYME INHIBITION; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE LOCUS; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; ADULT; COLORECTAL TUMOR; GENETICS; HUMAN GENOME; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; COLORECTAL NEOPLASMS; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENE DOSAGE; GENOME, HUMAN; HUMANS; MALE; MIDDLE AGED;

EID: 79959399677     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-50     Document Type: Article

References (40)

1. Distribution of colon neoplasia in Chinese patients: implications for endoscopic screening strategies. MS Soon A Soon TY Lin OS Lin, Eur J Gastroenterol Hepatol 2008 20 7 642 647 10.1097/MEG.0b013e3282f6482b 18679066
2. Increasing incidence of colorectal cancer in Asia: implications for screening. JJ Sung JY Lau KL Goh WK Leung, Lancet Oncol 2005 6 11 871 876 10.1016/S1470-2045(05)70422-8 16257795 (Pubitemid 41614799)
3. Cancer genes and the pathways they control. B Vogelstein KW Kinzler, Nat Med 2004 10 8 789 799 10.1038/nm1087 15286780 (Pubitemid 39070849)
4. The fundamental role of epigenetic events in cancer. PA Jones SB Baylin, Nat Rev Genet 2002 3 6 415 428 12042769 (Pubitemid 34587077)
5. The history of cancer epigenetics. AP Feinberg B Tycko, Nat Rev Cancer 2004 4 2 143 153 10.1038/nrc1279 14732866 (Pubitemid 38198742)
6. LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. S Ogino T Kawasaki K Nosho M Ohnishi Y Suemoto GJ Kirkner CS Fuchs, Int J Cancer 2008 122 12 2767 2773 10.1002/ijc.23470 18366060 (Pubitemid 351631379)
7. BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer. H Tanaka G Deng K Matsuzaki S Kakar GE Kim S Miura MH Sleisenger YS Kim, Int J Cancer 2006 118 11 2765 2771 10.1002/ijc.21701 16381005 (Pubitemid 43673355)
8. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. DJ Weisenberger KD Siegmund M Campan J Young TI Long MA Faasse GH Kang M Widschwendter D Weener D Buchanan, et al. Nat Genet 2006 38 7 787 793 10.1038/ng1834 16804544 (Pubitemid 43980599)
9. Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features. PW Ang M Loh N Liem PL Lim F Grieu A Vaithilingam C Platell WP Yong B Iacopetta R Soong, BMC Cancer 2010 10 227 10.1186/1471-2407-10-227 20492682
10. Effect of classification based on combination of mutation and methylation in colorectal cancer prognosis. H Aoyagi S Iida H Uetake T Ishikawa Y Takagi H Kobayashi T Higuchi M Yasuno M Enomoto K Sugihara, Oncol Rep 2011
11. Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients. E Chang DI Park YJ Kim BK Kim JH Park HJ Kim YK Cho CI Sohn WK Jeon BI Kim, et al. Hepatogastroenterology 2010 57 101 720 727 21033217
12. Two groups of DNA methylation markers to classify colorectal cancer into three epigenotypes. A Kaneda K Yagi, Cancer Sci 2011 102 1 18 24 10.1111/j.1349-7006.2010.01712.x 21159060
13. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. S Ogino M Cantor T Kawasaki M Brahmandam GJ Kirkner DJ Weisenberger M Campan PW Laird M Loda CS Fuchs, Gut 2006 55 7 1000 1006 10.1136/gut.2005.082933 16407376 (Pubitemid 43962613)
14. Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review. K Shima K Nosho Y Baba M Cantor JA Meyerhardt EL Giovannucci CS Fuchs S Ogino, Int J Cancer 2011 128 5 1080 1094 10.1002/ijc.25432 20473920
15. Three DNA methylation epigenotypes in human colorectal cancer. K Yagi K Akagi H Hayashi G Nagae S Tsuji T Isagawa Y Midorikawa Y Nishimura H Sakamoto Y Seto, et al. Clin Cancer Res 2010 16 1 21 33 10.1158/1078-0432.CCR-09-2006 20028768
16. DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines. S Houshdaran S Hawley C Palmer M Campan MN Olsen AP Ventura BS Knudsen CW Drescher ND Urban PO Brown, et al. PLoS One 2010 5 2 9359 10.1371/journal.pone. 0009359 20179752
17. Comparing 3 dietary pattern methods - cluster analysis, factor analysis, and index analysis - With colorectal cancer risk: The NIH-AARP Diet and Health Study. J Reedy E Wirfalt A Flood PN Mitrou SM Krebs-Smith V Kipnis D Midthune M Leitzmann A Hollenbeck A Schatzkin, et al. Am J Epidemiol 2010 171 4 479 487 10.1093/aje/kwp393 20026579
18. Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets. JM Ordway JA Bedell RW Citek A Nunberg A Garrido R Kendall JR Stevens D Cao RW Doerge Y Korshunova, et al. Carcinogenesis 2006 27 12 2409 2423 10.1093/carcin/bgl161 16952911 (Pubitemid 44884098)
19. Analysis of a multifactor microarray study using Partek genomics solution. T Downey, Methods Enzymol 2006 411 256 270 16939794 (Pubitemid 44291429)
20. The assumptions underlying the analysis of variance. C Eisenhart, Biometrics 1947 3 1 1 22 10.2307/3001534 20240414
21. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. A Subramanian P Tamayo VK Mootha S Mukherjee BL Ebert MA Gillette A Paulovich SL Pomeroy TR Golub ES Lander, et al. Proc Natl Acad Sci USA 2005 102 43 15545 15550 10.1073/pnas.0506580102 16199517 (Pubitemid 41528093)
22. Pre-validation and inference in microarrays. RJ Tibshirani B Efron, Stat Appl Genet Mol Biol 2002 1 rticle1 16646777
23. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. R Edgar M Domrachev AE Lash, Nucleic Acids Res 2002 30 1 207 210 10.1093/nar/30.1.207 11752295 (Pubitemid 34679544)
24. Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis. D Xie C Gore J Liu RC Pong R Mason G Hao M Long W Kabbani L Yu H Zhang, et al. Proc Natl Acad Sci USA 2010 107 6 2485 2490 10.1073/pnas.0908133107 20080667
25. DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis. D Xie C Gore J Zhou RC Pong H Zhang L Yu RL Vessella W Min JT Hsieh, Proc Natl Acad Sci USA 2009 106 47 19878 19883 19903888
26. Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis. B Garmy-Susini CJ Avraamides MC Schmid P Foubert LG Ellies L Barnes C Feral T Papayannopoulou A Lowy SL Blair, et al. Cancer Res 2010 70 8 3042 3051 10.1158/0008-5472.CAN-09-3761 20388801
27. DNA methylation markers in colorectal cancer. MS Kim J Lee D Sidransky, Cancer Metastasis Rev 2010 29 1 181 206 10.1007/s10555-010-9207-6 20135198
28. DNA hypomethylation in the origin and pathogenesis of human diseases. IP Pogribny FA Beland, Cell Mol Life Sci 2009 66 14 2249 2261 10.1007/s00018-009- 0015-5 19326048
29. Cancer epigenomics: DNA methylomes and histone-modification maps. M Esteller, Nat Rev Genet 2007 8 4 286 298 10.1038/nrg2005 17339880 (Pubitemid 46439286)
30. Human DNA repair genes. A Ronen BW Glickman, Environ Mol Mutagen 2001 37 3 241 283 10.1002/em.1033 11317342 (Pubitemid 32411130)
31. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. RA Irizarry C Ladd-Acosta B Wen Z Wu C Montano P Onyango H Cui K Gabo M Rongione M Webster, et al. Nat Genet 2009 41 2 178 186 10.1038/ng.298 19151715
32. Epigenomic Analysis of Aberrantly Methylated Genes in Colorectal Cancer Identifies Genes Commonly Affected by Epigenetic Alterations. YH Kim HC Lee SY Kim YI Yeom KJ Ryu BH Min DH Kim HJ Son PL Rhee JJ Kim, et al. Ann Surg Oncol 2011
33. Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas. B Oster K Thorsen P Lamy TK Wojdacz LL Hansen K Birkenkamp-Demtroder KD Sorensen S Laurberg TF Orntoft CL Andersen, Int J Cancer 2011
34. A study of the influence of sex on genome wide methylation. J Liu M Morgan K Hutchison VD Calhoun, PLoS One 2010 5 4 10028 10.1371/journal.pone. 0010028 20386599
35. Principles and challenges of genome-wide DNA methylation analysis. PW Laird, Nat Rev Genet 2010 11 3 191 203 20125086
36. Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer. Q He HY Chen EQ Bai YX Luo RJ Fu YS He J Jiang HQ Wang, Cancer Genet Cytogenet 2010 202 1 1 10 10.1016/j.cancergencyto.2010.05.018 20804913
37. Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancer. N Tanaka C Huttenhower K Nosho Y Baba K Shima J Quackenbush KM Haigis E Giovannucci CS Fuchs S Ogino, Am J Pathol 2010 177 6 2731 2740 10.2353/ajpath.2010.100361 21037082
38. Quantitative comparison of genome-wide DNA methylation mapping technologies. C Bock EM Tomazou AB Brinkman F Muller F Simmer H Gu N Jager A Gnirke HG Stunnenberg A Meissner, Nat Biotechnol 2010 28 10 1106 1114 10.1038/nbt.1681 20852634
39. Weisenberger, D. J. Comprehensive DNA methylation analysis on the Illumina Infinium assay platform (Illumina, San Diego, California, USA, 2008). http://www.illumina.com/Documents/products/appnotes/appnote-infinium- methylation.pdf
40. Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer. J Camps QT Nguyen HM Padilla-Nash T Knutsen NE McNeil D Wangsa AB Hummon M Grade T Ried MJ Difilippantonio, Genes Chromosomes Cancer 2009 48 11 1002 1017 10.1002/gcc.20699 19691111